Literature DB >> 15288618

A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.

A Mithat Bozdayi, Can Polat Eyigun, Ahmet R Turkyilmaz, Ismail Yasar Avci, Alaaddin Pahsa, Cihan Yurdaydin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15288618     DOI： 10.1016/j.jcv.2004.05.002

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


× No keyword cloud information.
  2 in total

1.  Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.

Authors:  Ke-zhou Liu; Wei Hou; Edward Zumbika; Qin Ni
Journal:  J Zhejiang Univ Sci B       Date:  2005-12       Impact factor: 3.066

2.  Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

Authors:  Fukiko Mitsui; Masataka Tsuge; Takashi Kimura; Shosuke Kitamura; Hiromi Abe; Hiromi Saneto; Tomokazu Kawaoka; Daiki Miki; Tsuyoshi Hatakeyama; Nobuhiko Hiraga; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Shoichi Takahashi; C Nelson Hayes; Harue Igarashi; Kentaro Morimoto; Masao Shimizu; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.